Panelists discuss that, based on EMERALD trial data, elacestrant provides consistent clinical benefit in metastatic breast ...

The frequency was calculated for each autosomal and X chromosome marker using 249 unrelated individuals and 188 unrelated females, respectively. Table 1 summarizes the size range and number of ...

Association of circulating tumor DNA (ctDNA) variant allelic frequency (VAF) with outcomes on matched targeted therapies (TT) in advanced non-small cell lung cancer (aNSCLC).. If you have the ...

Impact of variant allele frequency of mutant PTPN11 in AML: Single institution experience of 122 patients. Authors: Mansour Alfayez, Keyur Patel, Jorge E. Cortes, Tapan M. Kadia, Farhad Ravandi, ...